Low level laser treatment for masticatory muscle pain

ISRCTN ISRCTN95474981
DOI https://doi.org/10.1186/ISRCTN95474981
Secondary identifying numbers N/A
Submission date
28/08/2015
Registration date
10/09/2015
Last edited
04/11/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Myofascial pain is a long-term pain disorder, in which pain, tenderness and muscle spasms are felt in facial muscles. The masticatory muscles include all of the muscles that are responsible for movement of the jaw. These muscles are often the most affected in cases of myofascial pain, as their involvement in chewing (mastication) means that they are used a lot. Two of the most common points where this pain is felt are the masseter muscle, which is the main muscle involved in chewing, and the temporalis muscle, which is involved in closing the mouth and moving the mouth from side to side when chewing. Low-level laser therapy (LLLT) is a treatment which uses specific wavelengths of light to stimulate the cells in the body that repair tissue, reduce inflammation, and reduce pain. This non-invasive treatment has proven to be very effective for treating back and neck pain, as well as other long term pain conditions. The aim of this study is to investigate whether applying LLLT to the point of greatest pain would help to reduce masticatory muscle pain.

Who can participate?
Adults with a diagnosis of myofascial pain and natural posterior occlusion (the teeth at the back of the mouth are aligned correctly).

What does the study involve?
Participants are randomly allocated into one of three groups. For participants in the first group, the low level laser is applied precisely and continuously to the places where pain is greatest in the related muscle. For participants in the second group, the laser is applied to three previously chosen points on the masseter muscle and three points on the temporalis muscle. For participants in the third group, the laser device is switched on, but not programmed to target any particular points. Levels of pain and movement range are assessed before and after the laser treatment.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
Istanbul University Faculty of Dentistry Department of Prosthodontics (Turkey)

When is the study starting and how long is it expected to run for?
September 2010 to October 2011

Who is funding the study?
Istanbul University Faculty of Dentistry Department of Prosthodontics (Turkey)

Who is the main contact?
Dr Bilge Gokcen-Rohlig

Contact information

Dr Bilge Gokcen-Rohlig
Scientific

Istanbul University Faculty of Dentistry Department of Prosthodontics
Capa
Istanbul
34390
Türkiye

ORCiD logoORCID ID 0000-0003-3143-9668

Study information

Study designSingle-centre randomised controlled trial.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleEarly results of low-level laser application for masticatory muscle pain: a double-blind randomized clinical study
Study objectivesDirect application of low-level laser therapy (LLLT) at the point of greatest pain would reduce muscle pain to a greater degree than would application at pre-established points and placebo.
Ethics approval(s)Ethics Committee of the Istanbul University Faculty of Medicine , 10/05/2012, ref: 2011/1272-639
Health condition(s) or problem(s) studiedMasticatory pain
InterventionParticipants were divided randomly into three age- and sex-matched groups:
1. Laser group (LGI) in which low level laser is applied precisely and continuously to the greatest points of pain in the related muscle (masseter and/or temporalis).
2. Laser group II (LGII) in which LLLT is applied in the same manner to three predetermined points on the masseter muscle (superior [MS], middle [MM], and inferior [MI] points) and three points on the temporalis muscle (anterior [TA], middle, and posterior points)
3. Placebo group (PG) in which the laser device was switched on, but not programmed.
Intervention typeDevice
Pharmaceutical study type(s)
Phase
Drug / device / biological / vaccine name(s)
Primary outcome measureMandibular movement range (right, left and protrusion) before and after the assigned treatments, pain on palpation by masseter muscles on three points (superior, middle and inferior points), temporals muscles on three points (anterior, middle and posterior points) and pressure pain thresholds for the same points by algometer.
Secondary outcome measuresPressure pain thresholds of the examined muscles are investigated before and after each treatment via visual analogue score (VAS), before any after the treatments
Overall study start date01/09/2010
Completion date01/10/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants30
Key inclusion criteria1. Diagnosis of myofascial pain according to the Research Diagnostic Criteria for Temporomandibular Disorder (RDC/TMD)
2. Aged between 18–60 years
3. Natural posterior occlusion
Key exclusion criteria1.Disc displacement with reduction or without reduction with or without limited opening, arthralgia, arthritis, or arthrosis
2. General inflammatory connective tissue disease (e.g. rheumatoid arthritis)
3. Psychiatric disorder
4. Tumour
5. Hearth disease or pacemaker
7. Pregnancy
8. Symptoms that could be referred to other orofacial region diseases (e.g. toothache, neuralgia, migraine)
9. Treatment or medication use for headache or bruxism in the last 2 years
10. Local skin infection over the masseter muscle
Date of first enrolment01/09/2010
Date of final enrolment01/10/2011

Locations

Countries of recruitment

  • Türkiye

Study participating centre

Istanbul University Faculty of Dentistry Department of Prosthodontics
Istanbul universitesi dis hek. fak. cene yuz protezi 6.kat
Capa
Istanbul
34390
Türkiye

Sponsor information

Istanbul University Faculty of Dentistry Department of Prosthodontics
Hospital/treatment centre

Istanbul University Faculty of Dentistry Department of Prosthodontics
Capa
Istanbul
34390
Türkiye

ROR logo "ROR" https://ror.org/03a5qrr21

Funders

Funder type

University/education

Istanbul University Faculty of Dentistry Department of Prosthodontics

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planManuscript has been submitted to BMC Oral Health.
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 23/10/2015 Yes No

Editorial Notes

04/11/2015: Publication reference added.